In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dow Pharmaceutical Sciences Inc.

Division of Valeant Pharmaceuticals International/Dow Pharmaceutical Sciences Inc.
www.dowpharm.com

Latest From Dow Pharmaceutical Sciences Inc.

Valeant Backs Strategy With Solid Deal Record

Reiterating the strength of its M&A-heavy strategy, Valeant CEO Michael Pearson touted the company's deal record during its second quarter earnings call.

BioPharmaceutical North America

US Capitol Capsule: Drug price 'yellow' signs: market canaries or lemons?

The "troubling" trends in the rising costs to US consumers of prescription drugs, including generics, is a big yellow warning sign the biopharmaceutical market is out of balance, largely due to a lack of transparency in how medicines are priced, insisted Dr Stephen Schondelmeyer, a professor of pharmaceutical management and economics and director of the PRIME Institute at the University of Minnesota.

FDA launches 'Snapshot' subgroup data website

Following through on its pledge to make subgroup data, like sex, race and age, more transparent and available to the public, the FDA on 21 November launched a new website, dubbed Drug Trials Snapshot, intended to provide information about who was in the clinical trials and whether various demographic groups were part of the consideration of safety and efficacy in applications submitted to the agency.

Valeant Plans Sales Rep Increase, DTC Campaign For Jublia

Valeant has something to prove with the launch of Jublia, a topical treatment for toenail fungus, which it has held up as an example of its R&D strategy at work.

BioPharmaceutical Launches
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Valeant Pharmaceuticals International
  • Senior Management
  • Raymond W Anderson, VP, Fin., Admin. & CFO
    Steve Smith, VP, Mktg. & Bus. Dev.
  • Contact Info
  • Dow Pharmaceutical Sciences Inc.
    Phone: (707) 793-2600
    1330 Redwood Way
    Petaluma, CA 94954-1169
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register